Pre-operative Overall Survival Time Prediction for Glioblastoma Patients Using Deep Learning on Both Imaging Phenotype and Genotype
暂无分享,去创建一个
Qian Wang | Junfeng Lu | Han Zhang | Jinsong Wu | Dinggang Shen | Zhicheng Jiao | Abudumijiti Aibaidula | Zhenyu Tang | Yuyun Xu | Lei Jin | D. Shen | Han Zhang | Z. Jiao | Jinsong Wu | Zhenyu Tang | A. Aibaidula | Yuyun Xu | Qian Wang | Lei Jin | Junfeng Lu | Qian Wang | Junfeng Lu
[1] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[2] Andriy Fedorov,et al. Computational Radiomics System to Decode the Radiographic Phenotype. , 2017, Cancer research.
[3] R. Jain,et al. Deep learning for prediction of survival in idh wild-type gliomas , 2017, Journal of the Neurological Sciences.
[4] Isabelle Camby,et al. Present and potential future issues in glioblastoma treatment , 2006, Expert review of anticancer therapy.
[5] Jieping Ye,et al. Large-scale sparse logistic regression , 2009, KDD.
[6] Peter Chang,et al. Imaging Genetic Heterogeneity in Glioblastoma and Other Glial Tumors: Review of Current Methods and Future Directions. , 2018, AJR. American journal of roentgenology.
[7] Dinggang Shen,et al. 3D Deep Learning for Multi-modal Imaging-Guided Survival Time Prediction of Brain Tumor Patients , 2016, MICCAI.
[8] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[9] Bozena Kaminska,et al. Clinical and immunological correlates of long term survival in glioblastoma , 2018, Contemporary oncology.
[10] Chul-Kee Park,et al. The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas , 2017, Acta Neuropathologica Communications.
[11] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[12] G. Reifenberger,et al. MGMT promoter methylation in malignant gliomas: ready for personalized medicine? , 2010, Nature Reviews Neurology.
[13] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[14] R. Colen,et al. Imaging Genomics in Glioblastoma Multiforme: A Predictive Tool for Patients Prognosis, Survival, and Outcome. , 2016, Magnetic resonance imaging clinics of North America.
[15] Daniel J Brat,et al. Genetic Markers in Glioblastoma: Prognostic Significance and Future Therapeutic Implications: On: Impact of Genotype Morphology on the Prognosis of Glioblastoma. Schmidt MC Antweiler S, Urban N, et al. J Neuropathol Exp Neurol 2002;61:321–328. , 2003, Advances in anatomic pathology.
[16] R. F. Woolson. Wilcoxon Signed-Rank Test , 2008 .